Literature DB >> 33730315

The correct graft orientation during descemet membrane endothelial keratoplasty (DMEK) using the "bubble-tap" technique.

Georgios Perdikakis1, Sofia Fili2, Iraklis Vastardis3, Markus Kohlhaas2.   

Abstract

PURPOSE: To demonstrate a novel, alternative endothelium Descemet membrane layer (EDM) orientation method in Descemet membrane endothelial keratoplasty (DMEK) that does not involve prior ink or trepanation marking of the graft, or intraoperative ocular coherence tomography (OCT) guided graft implantation during surgery, thus preventing the occurrence of an upside-down graft implantation that leads with certainty to primary graft failure.
METHODS: From 2017 to early 2020, 500 eyes underwent DMEK operation using the "bubble-tap" technique first described from Dr. Perdikakis in the department of ophthalmology of St.-Johannes- Hospital in Dortmund in Germany. Primary graft failure and re-bubbling results following "bubble-tap" assisted DMEK are presented.
RESULTS: Primary graft failure due to upside-down graft implantation was not observed in any patient. Re-bubbling was performed in 4.8% of the eyes. In 1.8% of the cases, a re-DMEK was performed due to a graft failure.
CONCLUSION: The "bubble-tap" technique is a novel, reliable and easy to master orientation method of EDM that enables the surgeon to perform DMEK with safety even in complicated cases with poor visibility in the anterior chamber, while it yields superior or equal results in comparison to other graft marking methods or intraoperative OCT-guided graft implantation.

Entities:  

Keywords:  Bubble-tap technique; DMEK; Upside down

Year:  2021        PMID: 33730315     DOI: 10.1007/s10792-021-01786-1

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  1 in total

1.  Corneal transplant survival rate in glaucoma patients with multiple previous antiglaucoma surgeries.

Authors:  Sofia Fili; Kalliopi Kontopoulou; Nikolaos Bechrakis; Markus Kohlhaas
Journal:  Int Ophthalmol       Date:  2021-05-26       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.